Statement of Changes in Beneficial Ownership (4)
July 14 2021 - 7:20PM
Edgar (US Regulatory)
FORM 4
[ ]
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
|
OMB APPROVAL
OMB Number:
3235-0287
Estimated average burden
hours per response...
0.5
|
|
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
|
|
|
1. Name and Address of Reporting Person
*
EBERSMAN DAVID A |
2. Issuer Name and Ticker or Trading Symbol
CASTLIGHT HEALTH, INC.
[
CSLT
]
|
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
__X__ Director _____ 10% Owner
_____ Officer (give title below) _____ Other (specify below)
|
|
(Last)
(First)
(Middle)
C/O CASTLIGHT HEALTH, INC., 150 SPEAR STREET, SUITE 400 |
3. Date of Earliest Transaction
(MM/DD/YYYY)
7/12/2021 |
|
(Street)
SAN FRANCISCO, CA 94105
(City)
(State)
(Zip)
|
4. If Amendment, Date Original Filed
(MM/DD/YYYY)
|
6. Individual or Joint/Group Filing
(Check Applicable Line)
_X
_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
|
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
|
1.Title of Security
(Instr. 3)
|
2. Trans. Date
|
2A. Deemed Execution Date, if any
|
3. Trans. Code
(Instr. 8)
|
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
|
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
|
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)
|
7. Nature of Indirect Beneficial Ownership (Instr. 4)
|
|
Code
|
V
|
Amount
|
(A) or (D)
|
Price
|
| Class B Common Stock | 7/12/2021 | | C | | 260973 | A | (1)(2) | 595450 (3) | I | By family trust (4) |
| Class B Common Stock | | | | | | | | 70707 | D | |
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
|
1. Title of Derivate Security
(Instr. 3) | 2. Conversion or Exercise Price of Derivative Security | 3. Trans. Date | 3A. Deemed Execution Date, if any | 4. Trans. Code
(Instr. 8) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) | 6. Date Exercisable and Expiration Date | 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4) | 8. Price of Derivative Security
(Instr. 5) | 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) | 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) | 11. Nature of Indirect Beneficial Ownership (Instr. 4) |
| Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares |
| Director Stock Option (right to buy) | $0.84 | 7/12/2021 | | M | | | 260973 | (5) | 7/20/2021 | Class A Common Stock (1)(2) | 260973 | $0.00 | 0 | D | |
| Class A Common Stock | (1)(2) | 7/12/2021 | | M | | 260973 | | (1)(2) | (1)(2) | Class B Common Stock | 260973 | $0.00 | 289544 | D | |
| Class A Common Stock | (1)(2) | 7/12/2021 | | C | | | 260973 | (1)(2) | (1)(2) | Class B Common Stock | 260973 | $0.00 | 28571 | D | |
| Explanation of Responses: |
| (1) | Each share of issuer's Class A Common Stock is convertible at any time at the option of the holder into one (1) share of Class B Common Stock. In addition, each share of Class A Common Stock will convert automatically into one (1) share of Class B Common Stock upon the transfer, whether or not for value, to any transferee who is not a "Permitted Transferee", as defined in the issuer's Restated Certificate of Incorporation in effect as of the date hereof. The shares of Class A Common Stock have no expiration date. |
| (2) | Each share of the issuer's Class A Common Stock will convert automatically into one (1) share of Class B Common Stock upon the earliest to occur of the following: (a) the first date on which the number of shares of Class A Common Stock then outstanding is less than 15,340,384 shares, (b) March 19, 2024, or (c) a time and date approved in writing by holders of at least a majority of the then-outstanding shares of Class A Common Stock. |
| (3) | 334,477 shares previously reported as held directly by the Reporting Person are held by the family trust and are reflected as such in this Form 4. |
| (4) | The shares are held by The Ebersman Family Trust UTA dated 5/29/2002 of which the Reporting Person and his wife are co-trustees. |
| (5) | The stock option has fully vested and is immediately exercisable. |
Reporting Owners
|
| Reporting Owner Name / Address | Relationships |
| Director | 10% Owner | Officer | Other |
EBERSMAN DAVID A
C/O CASTLIGHT HEALTH, INC.
150 SPEAR STREET, SUITE 400
SAN FRANCISCO, CA 94105 | X |
|
|
|
Signatures
|
| /s/ Mary Ahern, as attorney-in-fact | | 7/14/2021 |
| **Signature of Reporting Person | Date |
Castlight Health (NYSE:CSLT)
Historical Stock Chart
From Jun 2024 to Jul 2024
Castlight Health (NYSE:CSLT)
Historical Stock Chart
From Jul 2023 to Jul 2024
